Title: HALL, W.H. and W.W. SPINK, Sulfamerazine: clinical evaluation in 116 cases. Journal of the American Medical Association, 1943. 123(3): p. 125-131.
127-79-7
100-90-3
1020719-78-1
127-73-1
1981-58-4
1189426-16-1
1272755-99-3 | Methyl 1-(2-methoxyethyl)-2-oxopyrrolidine-4-carboxylate | AA000WRA | MFCD18651721
1274904-48-1 | 1,2,2,3-Propanetetracarbonitrile | AA000X1N | MFCD10000963
1279106-02-3 | 5-Bromo-4-methyl-2-(methylsulfonyl)pyridine | AA000XGR | MFCD28397882
128073-01-8 | 3-Chloro-5-fluoropicolinic acid | AA000XOK | MFCD13185822
128404-37-5 | (S)-2,2,2-Trifluoro-1-phenylethylamine hcl | AA000XZ5 | MFCD07776797
1287753-32-5 | 3-(1-Methoxyethyl)phenylboronic acid | AA000YAP | MFCD08059828
129-43-1 | 1-Hydroxyanthraquinone | AA000YOP | MFCD00058946
129273-38-7 | 1H-Isoindole-1,3(2H)-dione, 2-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]hexahydro-, hydrochloride (1:1), (3aR,7aS)-rel- | AA000YXX | MFCD00890882
13156-11-1 | 3-Furancarboxylic acid, 2,5-dihydro-4,5,5-trimethyl-2-oxo- | AA000ZCT | MFCD00995668
131747-62-1 | 3-Trifluoromethyl-2-formylpyridine | AA000ZLG | MFCD07375387